Calamos Advisors’s Otonomy, Inc. OTIC Stock Holding History

Calamos Advisors’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,100	Closed	-$280K	–	656
2015 Q4	$280K	Buy	+10,100	New	+$251K	﹤0.01%	608

Other funds holding OTIC

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Calamos Advisors's OTIC Position: Q1 2016 in Review

Calamos Advisors sold out of Otonomy, Inc. (OTIC) in Q1 2016, closing a stake of 10,100 shares — an estimated $280K sold.

Calamos Advisors first reported a position in OTIC in Q4 2015 and held it in 1 quarter. The position peaked at $280K in Q4 2015. 89 funds tracked by Wall St. Rank hold OTIC as of Q1 2016.

Calamos Advisors reported no remaining Otonomy, Inc. position as of Q1 2016 after selling out during the quarter.
Calamos Advisors sold 10,100 Otonomy, Inc. shares in Q1 2016, an estimated $280K.
Calamos Advisors first reported a position in Otonomy, Inc. in Q4 2015 and held it in 1 quarter.
Calamos Advisors's Otonomy, Inc. position peaked at $280K in Q4 2015.
89 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q1 2016.

Based on Calamos Advisors's 13F filing for Q1 2016, filed 25 Apr 2016.